Citation Impact
Citing Papers
Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes
2015 Standout
An enzymatic toolkit for selective proteolysis, detection, and visualization of mucin-domain glycoproteins
2020 StandoutNobel
Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis
2018 Standout
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2024 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
The worldwide epidemiology of type 2 diabetes mellitus—present and future perspectives
2011 Standout
Restrictive versus liberal transfusion strategy for red blood cell transfusion: systematic review of randomised trials with meta-analysis and trial sequential analysis
2015
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
2020 Standout
Extrahepatic Manifestations of Nonalcoholic Fatty Liver Disease
2016
SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
2018 Standout
Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses
2018
The behaviour change wheel: A new method for characterising and designing behaviour change interventions
2011 Standout
Elevated Serum Alanine Aminotransferase and γ-Glutamyltransferase and Mortality in the United States Population
2008
Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide
2014 Standout
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
2013 Standout
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation
2015 Standout
Tuberculosis
2015
Hallmarks of aging: An expanding universe
2023 Standout
A position statement on NAFLD/NASH based on the EASL 2009 special conference
2010
Chronic hepatitis C virus infection and pathogenesis of hepatocellular carcinoma
2016
Structure-guided mutagenesis of a mucin-selective metalloprotease from Akkermansia muciniphila alters substrate preferences
2022 StandoutNobel
The function of adipocytes in the bone marrow stroma: an update
1996
NAFLD and diabetes mellitus
2016
Mendelian randomization: Using genes as instruments for making causal inferences in epidemiology
2007 Standout
TYGS is an automated high-throughput platform for state-of-the-art genome-based taxonomy
2019 Standout
From NAFLD in clinical practice to answers from guidelines
2013
Mechanisms of NAFLD development and therapeutic strategies
2018 Standout
Epidemiology and natural history of HCV infection
2013
Hepatitis C-related hepatocellular carcinoma in the era of new generation antivirals
2017
Acute kidney injury
2019 Standout
Non-alcoholic fatty liver disease
2021 Standout
Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association
2021 Standout
Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study
2019 Standout
Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Valve Stenosis
2015
Observer bias in randomized clinical trials with measurement scale outcomes: a systematic review of trials with both blinded and nonblinded assessors
2013
Novel biochemical risk factors for type 2 diabetes: pathogenic insights or prediction possibilities?
2008
Adiponectin Levels and Risk of Type 2 Diabetes
2009 Standout
Is network meta-analysis as valid as standard pairwise meta-analysis? It all depends on the distribution of effect modifiers
2013
Type 2 diabetes
2017 Standout
Association between trial registration and positive study findings: cross sectional study (Epidemiological Study of Randomized Trials—ESORT)
2017
Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity
2010
Meta-Regression Analyses, Meta-Analyses, and Trial Sequential Analyses of the Effects of Supplementation with Beta-Carotene, Vitamin A, and Vitamin E Singly or in Different Combinations on All-Cause Mortality: Do We Have Evidence for Lack of Harm?
2013
Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis
2013
Risk of type 2 diabetes in patients with non-alcoholic fatty liver disease: Causal association or epiphenomenon?
2016
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
2014 Standout
Evidence-based interventions for improvement of maternal and child nutrition: what can be done and at what cost?
2013 Standout
‘Small Changes' to Diet and Physical Activity Behaviors for Weight Management
2013 Standout
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement
2015 Standout
Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
2010 Standout
Mental health of young people: a global public-health challenge
2007 Standout
Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets
2016 Standout
Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
2015 Standout
Extrahepatic complications of nonalcoholic fatty liver disease
2013
Sulfonylurea versus metformin monotherapy in patients with type 2 diabetes: a Cochrane systematic review and meta-analysis of randomized clinical trials and trial sequential analysis
2014
Tumor Necrosis Factor Inhibits Spread of Hepatitis C Virus Among Liver Cells, Independent From Interferons
2017 StandoutNobel
Whole grain and refined grain consumption and the risk of type 2 diabetes: a systematic review and dose–response meta-analysis of cohort studies
2013
Nonalcoholic Fatty Liver: A Possible New Target for Type 2 Diabetes Prevention and Treatment
2013
Prevention of type 2 diabetes; a systematic review and meta‐analysis of different intervention strategies
2014
Mortality in Mental Disorders and Global Disease Burden Implications
2015 Standout
Laboratory-Confirmed Respiratory Infections as Predictors of Hospital Admission for Myocardial Infarction and Stroke: Time-Series Analysis of English Data for 2004–2015
2018
Nonalcoholic fatty liver disease incidence and impact on metabolic burden and death: A 20 year‐community study
2017
Psychological therapies for people with borderline personality disorder
2012
Strengthening the Reporting of Observational Studies in Epidemiology Using Mendelian Randomization
2021 Standout
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
2015 Standout
A Recombinant Hepatitis C Virus Genotype 1a E1/E2 Envelope Glycoprotein Vaccine Elicits Antibodies That Differentially Neutralize Closely Related 2a Strains through Interactions of the N-Terminal Hypervariable Region 1 of E2 with Scavenger Receptor B1
2019 StandoutNobel
Understanding Adipocyte Differentiation
1998 Standout
Dietary and Policy Priorities for Cardiovascular Disease, Diabetes, and Obesity
2016 Standout
Interventions for preventing obesity in children
2019 Standout
Fibrosis stage is the strongest predictor for disease‐specific mortality in NAFLD after up to 33 years of follow‐up
2014 Standout
The preregistration revolution
2018 Standout
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
Terlipressin versus other vasoactive drugs for hepatorenal syndrome
2017
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta‐analysis
2015
Viral persistence, liver disease, and host response in a hepatitis C–like virus rat model
2017 StandoutNobel
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Native Folding of a Recombinant gpE1/gpE2 Heterodimer Vaccine Antigen from a Precursor Protein Fused with Fc IgG
2016 StandoutNobel
Evidence Synthesis for Decision Making 3
2013
Nonalcoholic Fatty Liver Disease
2015 Standout
External beam radiotherapy for unresectable hepatocellular carcinoma
2017
Management of people with early- or very early-stage hepatocellular carcinoma
2017
SPIRIT 2013 Statement: Defining Standard Protocol Items for Clinical Trials
2013 Standout
Works of Ross Harris being referenced
Meta-analyses of Observational and Genetic Association Studies of Folate Intakes or Levels and Breast Cancer Risk
2006
Development of a combined database for meta‐epidemiological research
2010
Epidemiology of parainfluenza infection in England and Wales, 1998–2013: any evidence of change?
2017
Increased uptake and new therapies are needed to avert rising hepatitis C-related end stage liver disease in England: Modelling the predicted impact of treatment under different scenarios
2014
Hepatitis C prevalence in England remains low and varies by ethnicity: an updated evidence synthesis
2011
Alanine Aminotransferase, γ-Glutamyltransferase, and Incident Diabetes
2009
Updated Tests for Small-study Effects in Meta-analyses
2009
IL-1 beta inhibits adipocyte formation in human long-term bone marrow culture.
1993
Treatment of Latent Tuberculosis Infection
2014
Gamma-Glutamyltransferase Is Associated With Incident Vascular Events Independently of Alcohol Intake
2007
Influence of Reported Study Design Characteristics on Intervention Effect Estimates From Randomized, Controlled Trials
2012